ThetaPal ThetaPal

Manufacturing / Biological Products, Except Diagnostic Substances

FATE THERAPEUTICS INC

FATE

$2.57

+$0.07 (+2.80%)

Price as of Aug 4, 2026 21:58 UTC

200 M

Market Cap (Micro Cap)

7%

IV Rank

159.0%

Implied Volatility

Aug 05

Next Earnings

Technical Signals as of Aug 3
Mixed
4 of 7

Trend

  • Above 20-day average $2.56
  • Above 50-day average $2.40
  • Above 200-day average $1.74 · +43.4%
  • Moving averages stacked 20 > 50 > 200

Momentum

  • Golden cross (50/200)
  • Momentum cross (20/50) 75d ago

Volume

  • Below-average volume 0.5x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

0.00

Bullish skew

Implied Volatility

159.0%

0% percentile

IV vs Realized

Options rich

20d HV 141.4%

Options Heat Map

Delta-risk grid for FATE options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

0 buys 6 sells
Date Insider Title Type Shares Value
Jun 12, 2026 RASTETTER WILLIAM H Grant 87,900 $0
Jun 12, 2026 EPSTEIN ROBERT S Grant 87,900 $0
Jun 12, 2026 Redmile Group, LLC Grant 87,900 $0
Jun 12, 2026 Lee Michael Stewart Grant 87,900 $0
Jun 12, 2026 Hamill Laura Grant 175,800 $0
Jun 12, 2026 ABERNETHY MATT Grant 87,900 $0
Jun 12, 2026 Agarwal Shefali Grant 87,900 $0
Jun 12, 2026 Jooss Karin Grant 87,900 $0
Jun 12, 2026 Xu Yuan Grant 87,900 $0
Jun 12, 2026 RASTETTER WILLIAM H Other 87,900 $0

Politician Trades in FATE

Date Politician Party Type Amount
Jan 31, 2023 Daniel Goldman D Sale $1K-$15K

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Mar 31, 2026 Q1 2026 -$0.29 -$0.26 +9.0% Beat
Dec 31, 2025 Q4 2025 -$0.28 -$0.27 +1.9% Beat
Sep 30, 2025 Q3 2025 -$0.30 -$0.27 +9.1% Beat
Jun 30, 2025 Q2 2025 -$0.35 -$0.29 +17.0% Beat
Mar 31, 2025 Q1 2025 -$0.39 -$0.32 +18.1% Beat

Track FATE with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for FATE and your entire portfolio.